These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12462762)

  • 1. Issues and practices in multiple sclerosis.
    Burks JS; Arnason BG; Coyle PK; Ford CC; Noronha A; Rammohan KW
    Neurorehabil Neural Repair; 2002 Dec; 16(4):307-20. PubMed ID: 12462762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment optimisation in multiple sclerosis.
    Zaffaroni M
    Neurol Sci; 2005 Dec; 26 Suppl 4():S187-92. PubMed ID: 16388356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy for multiple sclerosis: the treatment strategy of the future?
    Weinstock-Guttman B; Bakshi R
    CNS Drugs; 2004; 18(12):777-92. PubMed ID: 15377168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future immunotherapies in multiple sclerosis.
    Blevins G; Martin R
    Semin Neurol; 2003 Jun; 23(2):147-58. PubMed ID: 12894380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.
    Stuart WH
    J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S19-25. PubMed ID: 15253686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis.
    Zhang J; Hutton G
    Annu Rev Med; 2005; 56():273-302. PubMed ID: 15660513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple sclerosis].
    Itoyama Y
    No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment modification in multiple sclerosis: classifications, alternatives, and the outcomes].
    Cendrowski W
    Neurol Neurochir Pol; 2007; 41(4):365-8. PubMed ID: 18027457
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic therapy of multiple sclerosis.
    Arnason BG
    Annu Rev Med; 1999; 50():291-302. PubMed ID: 10073279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: current knowledge and future outlook.
    Kamm CP; Uitdehaag BM; Polman CH
    Eur Neurol; 2014; 72(3-4):132-41. PubMed ID: 25095894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis update.
    Mayr WT; Rodriguez M
    Minn Med; 2002 Jun; 85(6):36-9. PubMed ID: 12092437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of pediatric multiple sclerosis.
    Yeh EA; Weinstock-Guttman B
    J Child Neurol; 2012 Nov; 27(11):1384-93. PubMed ID: 22914373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of mitoxantrone in the treatment of multiple sclerosis].
    Sivertseva SA; Zhuravlev MN; Shmurygina EA; Dekhtiarenko EV; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):100-6. PubMed ID: 19891353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and therapy in multiple sclerosis].
    Sailer M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 May; 45(5):328-34. PubMed ID: 20455189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
    Bandari DS; Sternaman D; Chan T; Prostko CR; Sapir T
    J Manag Care Pharm; 2012; 18(9):1-17. PubMed ID: 23206263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.